CVR number 27984274
Industry 10.8900 Manufacture of other food products n.e.c.

VETCUR BIOTEC ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  7.1% 7.1% 7.1% 7.1% 7.1%  
Bankruptcy risk  2.1% 2.6% 4.3% 4.9% 3.6%  
Credit score (0-100)  68 61 46 44 51  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.2 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  2,437 2,267 1,854 1,526 1,666  
EBITDA  590 397 -23.0 -17.5 199  
EBIT  545 366 -75.0 -71.6 145  
Pre-tax profit (PTP)  544.1 362.9 -82.0 -74.7 143.5  
Net earnings  414.0 284.8 -82.0 -49.7 104.8  
Pre-tax profit without non-rec. items  544 363 -82.0 -74.7 143  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  95.1 129 299 269 215  
Shareholders equity total  1,690 1,975 1,893 1,843 1,448  
Interest-bearing liabilities  140 66.2 46.0 37.9 289  
Balance sheet total (assets)  2,498 2,855 2,562 2,525 2,121  
Net Debt  -990 -1,338 -953 -857 -289  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,437 2,267 1,854 1,526 1,666  
Gross profit growth  7.7% -7.0% -18.2% -17.7% 9.1%  
Employees  5 5 4 4 4  
Employee growth %  0.0% 0.0% -20.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,498 2,855 2,562 2,525 2,121  
Balance sheet change%  17.7% 14.3% -10.3% -1.4% -16.0%  
Added value  589.8 397.0 -23.0 -19.6 198.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  18 3 118 -84 -108  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 -2.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  22.4% 16.1% -4.0% -4.7% 8.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.8% 14.0% -2.5% -2.7% 6.5%  
ROI %  34.2% 19.3% -3.5% -3.5% 7.9%  
ROE %  27.9% 15.5% -4.2% -2.7% 6.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  67.7% 69.2% 70.1% 73.0% 68.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -167.9% -337.0% 4,143.5% 4,888.5% -145.7%  
Gearing %  8.3% 3.4% 2.4% 2.1% 20.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.2% 10.3% 23.2% 15.2% 4.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.0 2.2 1.7 1.8 1.2  
Current Ratio  3.0 3.1 2.9 3.3 2.8  
Cash and cash equivalent  1,130.6 1,404.0 999.0 894.8 578.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,595.0 1,845.9 1,266.0 1,347.9 1,008.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  118 79 -6 -5 50  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  118 79 -6 -4 50  
EBIT / employee  109 73 -19 -18 36  
Net earnings / employee  83 57 -21 -12 26